Skip to main content

Table 3 Univariate and multivariate analysis of clinicopathologic variables associated with disease-free survival in 61 patients who underwent resection for primary retroperitoneal sarcoma

From: Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma

Variable

N (%)

5-year Disease-free Survival (%)

Univariate Analysis P

Multivariate Analysis*

P

Hazard Ratio (95% CI)

Sex

  

.649

  

Male

29 (48)

38

   

Female

32 (52)

32

   

BMI (Body Mass Index)

  

.635

  

 < 25

28 (46)

29

   

 ≥25

33 (54)

38

   

Patient age at resection

  

.006

NS

 

 ≥ 60 years

21 (35)

16

   

 18–59 years

38 (62)

47

   

 <  18 years

2 (3)

50

   

Tobacco use

  

.738

  

 Yes

15 (25)

40

   

 No

46 (75)

28

   

Tumour entity

  

.311

  

 Leiomyosarcoma

19 (31)

31

   

 Liposarcoma, dedifferentiated

14 (23)

22

   

 Liposarcoma, well-differentiated

12 (20)

33

   

 Undifferentiated sarcoma, NOS

8 (13)

25

   

 Liposarcoma, pleomorphic

3 (5)

39

   

 Malignant Peripheral Nerve Sheath Tumours

3 (5)

29

   

 Other

3 (5)

66

   

Histologic grade, n (%)

  

.018

.013

2.07 (1.17–3.66)

 Low grade (G1)

21 (34)

63

   

 Intermediate grade (G2)

11 (18)

24

   

 High grade (G3)

29 (48)

22

   

AJCC 8th Ed., n (%)

  

.004

NS

 

 Stage IA

2 (3)

85

   

 Stage IB

17 (28)

71

   

 Stage II

4 (7)

50

   

 Stage IIIA

8 (13)

36

   

 Stage IIIB

25 (41)

28

   

 Stage IV

5 (8)

0

   

Chemotherapy n (%)

  

.150

  

 None

49 (80)

34

   

 Neoadjuvant

2 (3)

50

   

 Adjuvant

10 (16)

31

   

Radiotherapy

  

.330

  

 None

44 (72)

33

   

 Neoadjuvant

4 (7)

50

   

 Adjuvant

13 (21)

66

   

Surgical resection margin

  

.047

.014

3.12 (1.26–7.72)

 R0

33 (54)

53

   

 R1

18 (30)

10

   

 R2

2 (3)

0

   

 RX / Not stated

8 (13)

44

   

Vascular involvement

  

.044

.001

5.04 (1.90–13.33)

 Yes

17 (28)

33

   

 No

44 (72)

39

   

ASA physical status

  

.659

  

 I

12 (20)

48

   

 II

32 (52)

36

   

 III

14 (23)

23

   

 IV

3 (5)

33

   

Need for intraoperative transfusions, %

  

.899

  

 No RBCC

32 (52)

38

   

 1–2 RBCC

13 (21)

41

   

 ≥ 3 RBCC

16 (26)

37

   
  1. * Cox regression multivariate analysis included all variables with P < 0.05 in univariate analysis. CI Confidence interval, NS Not significant, BMI Body-mass-index, ASA American Society of Anesthesiologists, AJCC American Joint Committee on Cancer Staging Manual, NOS Not otherwise specified, RBCC Red blood cell concentrate
  2. Entries with a p-value of < 0.05 in univariate or multivariate analysis are in boldface. A P value below 0.05 was considered significant.